New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
STIM-mediated calcium influx regulates maintenance and selection of germinal center B cells: Study

STIM-mediated calcium influx regulates maintenance and selection of germinal center B cells: Study

by Osaka UniversityCredit:Journal of Experimental Medicine(2023). DOI: 10.1084/jem.20222178Germinal centers (GCs) are specialized microenvironments where antigen (Ag)-specific B cells
Immunology & Rheumatology April 22,2024
STIM-mediated calcium influx regulates maintenance and selection of germinal center B cells: Study

STIM-mediated calcium influx regulates maintenance and selection of germinal center B cells: Study

by Osaka UniversityCredit:Journal of Experimental Medicine(2023). DOI: 10.1084/jem.20222178Germinal centers (GCs) are specialized microenvironments where antigen (Ag)-specific B cells
Immunology & Rheumatology April 22,2024
SARS-CoV-2 curtails immune response in the gut

SARS-CoV-2 curtails immune response in the gut

by European Molecular Biology LaboratoryThe researchers were able to monitor the virus's growth in organoids derived from human intestinal cells. Pink and red show areas of SARS-CoV-2 infecti
Immunology & Rheumatology April 22,2024
SARS-CoV-2 curtails immune response in the gut

SARS-CoV-2 curtails immune response in the gut

by European Molecular Biology LaboratoryThe researchers were able to monitor the virus's growth in organoids derived from human intestinal cells. Pink and red show areas of SARS-CoV-2 infecti
Immunology & Rheumatology April 22,2024
Genes and cellular processes that contribute to the pathogenesis of RVVC found

Genes and cellular processes that contribute to the pathogenesis of RVVC found

by Bob Yirka , Medical XpressCandida albicans. Credit: Wikipedia.An international team of researchers has identified some of the genes and cellular processes that contribute to the pathogenesis of rec
Immunology & Rheumatology April 22,2024
Genes and cellular processes that contribute to the pathogenesis of RVVC found

Genes and cellular processes that contribute to the pathogenesis of RVVC found

by Bob Yirka , Medical XpressCandida albicans. Credit: Wikipedia.An international team of researchers has identified some of the genes and cellular processes that contribute to the pathogenesis of rec
Immunology & Rheumatology April 22,2024
SRC-3 is a novel regulator of human immune T regulatory cells

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.
Immunology & Rheumatology April 22,2024
SRC-3 is a novel regulator of human immune T regulatory cells

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.
Immunology & Rheumatology April 22,2024
Phosphorylation of Regnase-1 lets IL-17 run amok

Phosphorylation of Regnase-1 lets IL-17 run amok

by Osaka UniversityCredit: CC0 Public DomainWhen considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unli
Immunology & Rheumatology April 22,2024
Phosphorylation of Regnase-1 lets IL-17 run amok

Phosphorylation of Regnase-1 lets IL-17 run amok

by Osaka UniversityCredit: CC0 Public DomainWhen considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unli
Immunology & Rheumatology April 22,2024
RNA sequencing used to discover novel genes and pathways in celiac disease

RNA sequencing used to discover novel genes and pathways in celiac disease

by Massachusetts General HospitalCredit: CC0 Public DomainResearchers at the Mucosal Immunology and Biology Research Center at MassGeneral Hospital for Children (MGHfC) have discovered novel gene
Immunology & Rheumatology April 22,2024
RNA sequencing used to discover novel genes and pathways in celiac disease

RNA sequencing used to discover novel genes and pathways in celiac disease

by Massachusetts General HospitalCredit: CC0 Public DomainResearchers at the Mucosal Immunology and Biology Research Center at MassGeneral Hospital for Children (MGHfC) have discovered novel gene
Immunology & Rheumatology April 22,2024
How SARS-CoV-2 hijacks human cells to evade immune system

How SARS-CoV-2 hijacks human cells to evade immune system

by University of California - San DiegoHuman enzyme METTL3 adds methyl groups to introduce m6A in SARS-CoV-2’s RNA. That modification prevents the virus’ RNA from triggering inflammatory molecule
Public Health & Prevention April 22,2024
How SARS-CoV-2 hijacks human cells to evade immune system

How SARS-CoV-2 hijacks human cells to evade immune system

by University of California - San DiegoHuman enzyme METTL3 adds methyl groups to introduce m6A in SARS-CoV-2’s RNA. That modification prevents the virus’ RNA from triggering inflammatory molecule
Public Health & Prevention April 22,2024
Snapshot turns T cell immunology on its head

Snapshot turns T cell immunology on its head

by Monash UniversityChallenging a universally accepted, longstanding consensus in the field of immunity requires hard evidence. New research from the Australian Research Council Centre of excelle
Immunology & Rheumatology April 22,2024
Snapshot turns T cell immunology on its head

Snapshot turns T cell immunology on its head

by Monash UniversityChallenging a universally accepted, longstanding consensus in the field of immunity requires hard evidence. New research from the Australian Research Council Centre of excelle
Immunology & Rheumatology April 22,2024
S1P molecule regulates dendritic cell localization and vascular integrity in lymph nodes

S1P molecule regulates dendritic cell localization and vascular integrity in lymph nodes

by Osaka UniversityCredit: Osaka UniversityThe trafficking of white blood cells called lymphocytes is crucial for controlling our immune response. Maintaining the integrity of high endothelial ve
Immunology & Rheumatology April 22,2024
S1P molecule regulates dendritic cell localization and vascular integrity in lymph nodes

S1P molecule regulates dendritic cell localization and vascular integrity in lymph nodes

by Osaka UniversityCredit: Osaka UniversityThe trafficking of white blood cells called lymphocytes is crucial for controlling our immune response. Maintaining the integrity of high endothelial ve
Immunology & Rheumatology April 22,2024
St18 is a negative regulator of VEGF

St18 is a negative regulator of VEGF

by National Institutes of Natural SciencesSt18 inhibits VEGF expression via Sp1 suppression. Credit: Kenta MaruyamaPro-inflammatory cytokines and pathogen-associated molecular patterns such as lipopol
Immunology & Rheumatology April 22,2024
St18 is a negative regulator of VEGF

St18 is a negative regulator of VEGF

by National Institutes of Natural SciencesSt18 inhibits VEGF expression via Sp1 suppression. Credit: Kenta MaruyamaPro-inflammatory cytokines and pathogen-associated molecular patterns such as lipopol
Immunology & Rheumatology April 22,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com